← Leaderboards
Anne Goldfeld
Immune Disease Institute, Inc.
$23,923,693
Attributed
$51,270,629
Total exposure
22
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$51,270,629 · 22
By mechanism
U19$30,000,379 · 6
R01$13,992,926 · 5
R56$2,992,189 · 5
R21$2,505,407 · 5
R35$1,779,728 · 1
Top collaborators
- Darrell P Chandler31 shared
- Aedin C Culhane31 shared
- Molly Forrest Franke31 shared
- Jerome Timothy Galea31 shared
- Louise Catherine Ivers31 shared
- Ann Chesney Miller31 shared
- Nira Pollock31 shared
- Eric Joseph Rubin31 shared
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisCellsTuberculosisBaseInfectionGenesDiagnosisInnovationMacrophageMonocyteDrug ResistanceDiagnosticGene ExpressionGenetic TranscriptionSiteLeadDesignImmuneDiagnostic TestsT-LymphocyteMediatingRegulationResponsePharmaceutical Preparations
Grant awards (84)
Human cellular models of TB and innate immunity$489,500
R21 · FY2025 · AI · contact PI
Discovery of novel regulatory territories in the TNF/LT locus$442,500
R35 · FY2025 · GM · contact PI
Discovery of novel regulatory territories in the TNF/LT locus$442,500
R35 · FY2024 · GM · contact PI
Discovery of novel regulatory territories in the TNF/LT locus$9,728
R35 · FY2024 · GM · contact PI
Discovery of novel regulatory territories in the TNF/LT locus$442,500
R35 · FY2023 · GM · contact PI
Discovery of novel regulatory territories in the TNF/LT locus$442,500
R35 · FY2022 · GM · contact PI
Innate Immune Control of TB and HIV$646,050
R56 · FY2021 · AI · contact PI
Host factors and inhibition of Filoviruses$209,375
R21 · FY2021 · AI · contact PI
TB-induced immunity in HIV-infected and uninfected individuals$566,990
R56 · FY2020 · AI · contact PI
Host factors and inhibition of Filoviruses$270,500
R21 · FY2020 · AI · contact PI
Immune control mechanisms of TB latency in the setting of HIV co-infection$442,500
R01 · FY2019 · AI · contact PI
Checkpoints of TNF Gene Regulation$424,800
R01 · FY2019 · GM · contact PI
Sequencing Core$2,595,356
U19 · FY2018 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$1,274,314
U19 · FY2018 · AI
Discovery and validation of drug resistance mutations$938,261
U19 · FY2018 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$888,730
U19 · FY2018 · AI
Immune control mechanisms of TB latency in the setting of HIV co-infection$442,500
R01 · FY2018 · AI · contact PI
Checkpoints of TNF Gene Regulation$424,800
R01 · FY2018 · GM · contact PI
Administrative Core$412,046
U19 · FY2018 · AI
Integrated system for Category C infectious disease diagnostics in resource-limi$403,448
U19 · FY2018 · AI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,182,203
U19 · FY2017 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$1,095,803
U19 · FY2017 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$913,253
U19 · FY2017 · AI
Discovery and validation of drug resistance mutations$734,112
U19 · FY2017 · AI
Administrative Core$616,131
U19 · FY2017 · AI
Immune control mechanisms of TB latency in the setting of HIV co-infection$442,500
R01 · FY2017 · AI · contact PI
Checkpoints of TNF Gene Regulation$424,800
R01 · FY2017 · GM · contact PI
Sequencing Core$408,777
U19 · FY2017 · AI
Immunity to TB in highly immunosuppressed HIV-infected and uninfected individuals$218,384
R21 · FY2017 · AI · contact PI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,528,705
U19 · FY2016 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$992,134
U19 · FY2016 · AI
Discovery and validation of drug resistance mutations$750,894
U19 · FY2016 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$715,308
U19 · FY2016 · AI
Immune control mechanisms of TB latency in the setting of HIV co-infection$442,500
R01 · FY2016 · AI · contact PI
Checkpoints of TNF Gene Regulation$424,800
R01 · FY2016 · GM · contact PI
Sequencing Core$421,675
U19 · FY2016 · AI
Administrative Core$410,524
U19 · FY2016 · AI
Immunity to TB in highly immunosuppressed HIV-infected and uninfected individuals$269,748
R21 · FY2016 · AI · contact PI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$82,633
U19 · FY2016 · AI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,500,809
U19 · FY2015 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$932,090
U19 · FY2015 · AI
Host factors, inflammation, and HIV associated TB$812,899
R56 · FY2015 · HL · contact PI
Discovery and validation of drug resistance mutations$774,241
U19 · FY2015 · AI
Sequencing Core$660,525
U19 · FY2015 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$500,331
U19 · FY2015 · AI
Checkpoints of TNF Gene Regulation$441,667
R01 · FY2015 · GM · contact PI
Immune control mechanisms of TB latency in the setting of HIV co-infection$441,250
R56 · FY2015 · AI · contact PI
Administrative Core$311,434
U19 · FY2015 · AI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,916,905
U19 · FY2014 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$900,727
U19 · FY2014 · AI
Sequencing Core$822,385
U19 · FY2014 · AI
Discovery and validation of drug resistance mutations$554,926
U19 · FY2014 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$536,059
U19 · FY2014 · AI
Checkpoints of TNF Gene Regulation$452,973
R01 · FY2014 · GM · contact PI
Administrative Core$225,640
U19 · FY2014 · AI
Checkpoints of TNF Gene Regulation$7,290
R01 · FY2014 · GM · contact PI
Checkpoints of TNF Gene Regulation$358,071
R01 · FY2013 · GM · contact PI
Checkpoints of TNF Gene Regulation$227,980
R01 · FY2012 · GM · contact PI
Checkpoints of TNF Gene Regulation$160,764
R01 · FY2012 · GM · contact PI
Checkpoints of TNF Gene Regulation$414,000
R01 · FY2011 · GM · contact PI
HIV-1 regulation by MTb: pathogen and host factor$525,000
R56 · FY2010 · AI · contact PI
T CELL SUBSETS AND THEIR FUNCTION IN TB/HIV PARADOXICAL REACTIONS$207,900
R21 · FY2010 · AI · contact PI
HIV-1 regulation by MTb: pathogen and host factor$488,336
R01 · FY2009 · AI · contact PI
Checkpoints of TNF Gene Regulation$377,234
R01 · FY2009 · GM · contact PI
T CELL SUBSETS AND THEIR FUNCTION IN TB/HIV PARADOXICAL REACTIONS$367,500
R21 · FY2009 · AI · contact PI
HIV-1 regulation by MTb: pathogen and host factor$440,433
R01 · FY2008 · AI · contact PI
Checkpoints of TNF Gene Regulation$340,229
R01 · FY2008 · GM · contact PI
HIV-1 regulation by MTb: pathogen and host factor$448,963
R01 · FY2007 · AI · contact PI
Checkpoints of TNF Gene Regulation$340,229
R01 · FY2007 · GM · contact PI
GENETIC FACTORS AND SUSCEPTIBILITY TO TUBERCULOSIS$631,868
R01 · FY2006 · HL · contact PI
HIV-1 regulation by MTb: pathogen and host factor$462,373
R01 · FY2006 · AI · contact PI
Checkpoints of TNF Gene Regulation$350,390
R01 · FY2006 · GM · contact PI
GENETIC FACTORS AND SUSCEPTIBILITY TO TUBERCULOSIS$630,297
R01 · FY2005 · HL
HIV-1 regulation by MTb: pathogen and host factor$236,750
R01 · FY2005 · AI
GENETIC FACTORS AND SUSCEPTIBILITY TO TUBERCULOSIS$614,730
R01 · FY2004 · HL
Clade-specific regulation of HIV-1 by M tuberculosis$472,500
R21 · FY2004 · AI
GENETIC FACTORS AND SUSCEPTIBILITY TO TUBERCULOSIS$599,399
R01 · FY2003 · HL
IMMUNOLOGICAL ACTIVATION OF TNF ALPHA GENE EXPRESSION$112,247
R01 · FY2003 · GM
GENETIC FACTORS AND SUSCEPTIBILITY TO TUBERCULOSIS$573,150
R01 · FY2002 · HL
IMMUNOLOGICAL ACTIVATION OF TNF ALPHA GENE EXPRESSION$345,147
R01 · FY2002 · GM
GENETIC FACTORS AND SUSCEPTIBILITY TO TUBERCULOSIS$399,400
R01 · FY2001 · HL
IMMUNOLOGICAL ACTIVATION OF TNF ALPHA GENE EXPRESSION$338,448
R01 · FY2001 · GM
GENETIC FACTORS AND SUSCEPTIBILITY TO TUBERCULOSIS$399,400
R01 · FY2000 · HL
IMMUNOLOGICAL ACTIVATION OF TNF ALPHA GENE EXPRESSION$331,958
R01 · FY2000 · GM